Skip to main content
Top
Published in: BMC Public Health 1/2015

Open Access 01-12-2015 | Research article

Trajectory analyses of virologic outcomes reflecting community-based HIV treatment in Washington DC 1994–2012

Authors: Joanne Michelle F. Ocampo, Michael Plankey, Kai Zou, Jeff Collmann, Cuiwei Wang, Mary A. Young, Chenglong Liu, Joshua A. Ripple, Seble Kassaye

Published in: BMC Public Health | Issue 1/2015

Login to get access

Abstract

Background

Effective treatment of HIV since 1996 has reduced morbidity and mortality through virologic suppression. Combination antiretroviral therapy (cART) has been recognized as key to the prevention of drug resistance and the transmission of infection. We used eighteen years of virologic outcomes in a long-standing cohort of women to describe longitudinal viral load trajectories; and examine factors associated with sustained viremia and mortality.

Methods

We analyzed data from DC WIHS women with > four semiannual visits using a group-based logistic trajectory analysis approach to identify patterns of HIV RNA detection (>80 copies/mL or lower assay limit, and >1000 copies/mL). We verified findings using cumulative viral load suppression-years, explored group characteristics using generalized linear modeling with generalized estimating equations for repeated measures, and examined survival using the Kaplan-Meier and Cox proportional hazard analyses.

Results

329 women contributed 6633 visits between 1994 and 2012 and demonstrated high, moderate, and low probability patterns of HIV RNA detection (>80 copies/mL) in 40.7, 35.6, and 23.7 % of participant visits, respectively. Analysis of cumulative years of viral load suppression supported these observations. Kaplan-Meier survival analysis demonstrated high mortality of 31.1 % with sustained viremia, but no significant difference in mortality between intermittent viremia and non-viremia patterns, 6.9 and 4.9 % respectively. Mortality was associated with higher age, lower CD4+ T lymphocyte count, and sustained viremia by Cox multivariate analysis.

Conclusions

This ecologic study demonstrates the effectiveness of viral suppression, and conversely the association between viremia and mortality. In community delivery of cART for HIV care, distinct patterns of sustained viremia, intermittent viremia, and non-viremia were identified over nearly 18 years in the DC WIHS, capturing the dynamics and complexity of sustaining long-term HIV care. Persistent viremia was associated with lower CD4s and mortality, but surprisingly mortality was not different between continuous suppression and intermittent viremia. Classification of long-term virologic patterns such as these observed HIV treatment “careers” may provide a suitable framework to identify modifiable factors associated with treatment resilience and failure. Both individual and population interventions are needed to reduce transmission, prevent the emergence of drug resistance, and improve outcomes of community ART programs.
Literature
1.
go back to reference Cohen SM, Van Handel MM, Branson BM, et al. Vital signs: HIV prevention through care and treatment — United States. MMWR. 2011;60(47):1618–23. Cohen SM, Van Handel MM, Branson BM, et al. Vital signs: HIV prevention through care and treatment — United States. MMWR. 2011;60(47):1618–23.
2.
go back to reference Thompson MA, Aberg JA, Cahn P, et al. Antiretroviral treatment of adult HIV infection 2010 recommendations of the International AIDS Society-USA panel. JAMA. 2010;304(3):321–33.CrossRefPubMed Thompson MA, Aberg JA, Cahn P, et al. Antiretroviral treatment of adult HIV infection 2010 recommendations of the International AIDS Society-USA panel. JAMA. 2010;304(3):321–33.CrossRefPubMed
3.
go back to reference Ikard K, Janney J, Hsu LC, et al. Estimation of unmet need for HIV primary medical care: a framework and three case studies. AIDS Ed Prev. 2005;17:26–38.CrossRef Ikard K, Janney J, Hsu LC, et al. Estimation of unmet need for HIV primary medical care: a framework and three case studies. AIDS Ed Prev. 2005;17:26–38.CrossRef
4.
go back to reference Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793–800.CrossRefPubMedPubMedCentral Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793–800.CrossRefPubMedPubMedCentral
5.
go back to reference Velasco-Hernandez JX, Gershengorn HB, Blower SM. Could widespread use of combination antiretroviral therapy eradicate HIV epidemics. Lancet Inf Dis. 2002;2:487–93.CrossRef Velasco-Hernandez JX, Gershengorn HB, Blower SM. Could widespread use of combination antiretroviral therapy eradicate HIV epidemics. Lancet Inf Dis. 2002;2:487–93.CrossRef
6.
go back to reference Craw JA, Gardner LI, Marks G, et al. Brief strengths-based case management promotes entry into HIV medical care results of the antiretroviral treatment access study-II. J Acquir Immune Defic Syndr. 2008;47(5):597–606.CrossRefPubMed Craw JA, Gardner LI, Marks G, et al. Brief strengths-based case management promotes entry into HIV medical care results of the antiretroviral treatment access study-II. J Acquir Immune Defic Syndr. 2008;47(5):597–606.CrossRefPubMed
7.
go back to reference Torian LV, Wiewel EW, Liu K, Sackoff JE, Frieden TR. Risk factors for delayed initiation of medical care after diagnosis of Human Immunodeficiency Virus. Arch Intern Med. 2008;168(11):1181–7.CrossRefPubMed Torian LV, Wiewel EW, Liu K, Sackoff JE, Frieden TR. Risk factors for delayed initiation of medical care after diagnosis of Human Immunodeficiency Virus. Arch Intern Med. 2008;168(11):1181–7.CrossRefPubMed
8.
go back to reference Gardner EM. The HIV engagement in care cascade. In: Program and abstracts of the 19th International AIDS Conference (Washington). Washington, DC: International AIDS Society; 2012. Gardner EM. The HIV engagement in care cascade. In: Program and abstracts of the 19th International AIDS Conference (Washington). Washington, DC: International AIDS Society; 2012.
9.
go back to reference Mugavero MJ, Amico KR, Horn T, Thompson MA. The state of engagement in HIV care in the United States: from cascade to continuum to control. Clin Infect Dis. 2013;57(8):1164–71. doi:10.1093/cid/cit420. Epub 2013 Jun 23.CrossRefPubMed Mugavero MJ, Amico KR, Horn T, Thompson MA. The state of engagement in HIV care in the United States: from cascade to continuum to control. Clin Infect Dis. 2013;57(8):1164–71. doi:10.​1093/​cid/​cit420. Epub 2013 Jun 23.CrossRefPubMed
10.
go back to reference Pavalko EK, Harding CM, Pescosolido BA. Mental illness careers in an era of change. Soc Probl. 2007;54(4):504–22.CrossRef Pavalko EK, Harding CM, Pescosolido BA. Mental illness careers in an era of change. Soc Probl. 2007;54(4):504–22.CrossRef
11.
go back to reference Cuzzocrea V, Lyon D. Sociological conceptualisations of “career”: a review and reorientation. Sociology Compass. 2011;5(12):1029–43.CrossRef Cuzzocrea V, Lyon D. Sociological conceptualisations of “career”: a review and reorientation. Sociology Compass. 2011;5(12):1029–43.CrossRef
12.
go back to reference Gove WR. The career of the mentally ill: an integration of psychiatric, labeling/social construction, and lay perspectives. JHSB. 2004;45:357–75. Gove WR. The career of the mentally ill: an integration of psychiatric, labeling/social construction, and lay perspectives. JHSB. 2004;45:357–75.
15.
go back to reference Jones BL, Nagin DS. Advances in group-based trajectory modeling and an SAS procedure for estimating them. SMR. 2007;35:542–71. Jones BL, Nagin DS. Advances in group-based trajectory modeling and an SAS procedure for estimating them. SMR. 2007;35:542–71.
16.
go back to reference Jones BL, Nagin DS, Roeder K. A SAS procedure based on mixture models for estimating developmental trajectories. SMR. 2001;29(3):374–93. Jones BL, Nagin DS, Roeder K. A SAS procedure based on mixture models for estimating developmental trajectories. SMR. 2001;29(3):374–93.
17.
go back to reference Bacon M, Von Wyl V, Alden C, et al. The Woman’s Interagency HIV Study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol. 2005;12(9):1013–9.PubMedPubMedCentral Bacon M, Von Wyl V, Alden C, et al. The Woman’s Interagency HIV Study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol. 2005;12(9):1013–9.PubMedPubMedCentral
18.
go back to reference Barkan SE, Melnick SL, Preston-Martin S, et al. The Women’s Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology. 1998;9:117–25.CrossRefPubMed Barkan SE, Melnick SL, Preston-Martin S, et al. The Women’s Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology. 1998;9:117–25.CrossRefPubMed
19.
go back to reference Calvelli T, Denny TN, Paxton H, Gelman R, Kagan J. Guidelines for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry. 1993;14:702–15.CrossRefPubMed Calvelli T, Denny TN, Paxton H, Gelman R, Kagan J. Guidelines for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry. 1993;14:702–15.CrossRefPubMed
20.
go back to reference Cohen MH, French AL, Benning L, et al. Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy. Am J Med. 2002;113:91–8.CrossRefPubMedPubMedCentral Cohen MH, French AL, Benning L, et al. Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy. Am J Med. 2002;113:91–8.CrossRefPubMedPubMedCentral
21.
go back to reference French AL, Gawel SH, Hershow R, et al. Trends in mortality and causes of death among women with HIV in the United States: a 10-year study. J Acquir Immune Defic Syndr. 2009;51:399–406.CrossRefPubMedPubMedCentral French AL, Gawel SH, Hershow R, et al. Trends in mortality and causes of death among women with HIV in the United States: a 10-year study. J Acquir Immune Defic Syndr. 2009;51:399–406.CrossRefPubMedPubMedCentral
22.
go back to reference Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measur. 1977;1:385–401.CrossRef Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measur. 1977;1:385–401.CrossRef
26.
go back to reference Mascolini M. Cumulative Viral Load Predicts All-Cause and AIDS Death But Not Non-AIDS Death. In: Program and abstracts of the 21st Conference on Retroviruses and Opportunistic Infections (Boston). San Francisco: International Antiviral Society; 2014. Mascolini M. Cumulative Viral Load Predicts All-Cause and AIDS Death But Not Non-AIDS Death. In: Program and abstracts of the 21st Conference on Retroviruses and Opportunistic Infections (Boston). San Francisco: International Antiviral Society; 2014.
28.
go back to reference Nosyk B, Montaner JS, Colley G, STOP HIV/AIDS Study Group, et al. The cascade of HIV care in British Columbia, Canada, 1996–2011: a population-based retrospective cohort study. Lancet Infect Dis. 2014;14(1):40–9. doi:10.1016/S1473-3099(13)70254-8. Epub 2013 Sep 25.CrossRefPubMed Nosyk B, Montaner JS, Colley G, STOP HIV/AIDS Study Group, et al. The cascade of HIV care in British Columbia, Canada, 1996–2011: a population-based retrospective cohort study. Lancet Infect Dis. 2014;14(1):40–9. doi:10.​1016/​S1473-3099(13)70254-8. Epub 2013 Sep 25.CrossRefPubMed
29.
go back to reference Strategies for Management of Antiretroviral Therapy (SMART) Study Group, El-Sadr WM, Lundgren J, Neaton JD, et al. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355(22):2283–96. doi:10.1056/NEJMoa062360.CrossRef Strategies for Management of Antiretroviral Therapy (SMART) Study Group, El-Sadr WM, Lundgren J, Neaton JD, et al. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355(22):2283–96. doi:10.​1056/​NEJMoa062360.CrossRef
30.
go back to reference Sullivan KA, Messer LC, Quinlivan EB. Substance Abuse, Violence, and HIV/AIDS (SAVA) Syndemic Effects on Viral Suppression Among HIV Positive Women of Color. AIDS Patient Care STDs 2014. doi: 10.1089/apc.2014.0278. Epub ahead of print Sullivan KA, Messer LC, Quinlivan EB. Substance Abuse, Violence, and HIV/AIDS (SAVA) Syndemic Effects on Viral Suppression Among HIV Positive Women of Color. AIDS Patient Care STDs 2014. doi: 10.1089/apc.2014.0278. Epub ahead of print
31.
go back to reference Santos GM, Wilson EC, Rapues J, Macias O, Packer T, Raymond HF. HIV treatment cascade among transgender women in a San Francisco respondent driven sampling study. Sex Transm Infect. 2014;90(5):430–3. doi:10.1136/sextrans-2013-051342. Epub 2014 Apr 8.CrossRefPubMed Santos GM, Wilson EC, Rapues J, Macias O, Packer T, Raymond HF. HIV treatment cascade among transgender women in a San Francisco respondent driven sampling study. Sex Transm Infect. 2014;90(5):430–3. doi:10.​1136/​sextrans-2013-051342. Epub 2014 Apr 8.CrossRefPubMed
32.
go back to reference Lampe FC, Harding R, Smith CJ, Phillips AN, Johnson M, Sherr L. Physical and psychological symptoms and risk of virologic rebound among patients with virologic suppression on antiretroviral therapy. J Acquir Immune Defic Syndr. 2010;54(5):500–5. doi:10.1097/QAI.0b013e3181ce6afe.CrossRefPubMed Lampe FC, Harding R, Smith CJ, Phillips AN, Johnson M, Sherr L. Physical and psychological symptoms and risk of virologic rebound among patients with virologic suppression on antiretroviral therapy. J Acquir Immune Defic Syndr. 2010;54(5):500–5. doi:10.​1097/​QAI.​0b013e3181ce6afe​.CrossRefPubMed
Metadata
Title
Trajectory analyses of virologic outcomes reflecting community-based HIV treatment in Washington DC 1994–2012
Authors
Joanne Michelle F. Ocampo
Michael Plankey
Kai Zou
Jeff Collmann
Cuiwei Wang
Mary A. Young
Chenglong Liu
Joshua A. Ripple
Seble Kassaye
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2015
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-015-2653-x

Other articles of this Issue 1/2015

BMC Public Health 1/2015 Go to the issue